GLICARYL; MV 80/0.3MG (Voglibose (0.3mg) + Metformin (500mg) + Gliclazide (80mg))

Glicaryl MV 80.3 Tablet is classified as an anti-diabetic medication and is primarily utilized for managing type 2 diabetes mellitus in adults. This formulation is a blend of multiple agents that work together to assist in the regulation of blood glucose levels for individuals diagnosed with diabetes. It is recommended to take Glicaryl MV 80.3 Tablet alongside food for optimal results, and adherence to a consistent daily schedule is crucial to maximize its effectiveness. The prescribing physician will determine the appropriate dosage, which may be adjusted periodically based on the patient’s blood sugar readings and overall response to treatment. It is essential to continue using this medication even if you feel well or your blood sugar levels appear stable. Abruptly discontinuing the medication without medical guidance may lead to an increase in blood glucose, raising the potential for serious complications such as kidney impairment, vision loss, nerve damage, and amputations. This medication should be part of a broader management strategy that includes a balanced diet, consistent physical activity, and weight management as recommended by your healthcare provider. Lifestyle modifications play a significant role in diabetes management. A key side effect to monitor is hypoglycemia, which is characterized by low blood sugar levels. Familiarize yourself with the symptoms of hypoglycemia—like sweating, dizziness, headaches, and trembling—and understand how to respond effectively. To mitigate this risk, maintain a routine of regular meals and keep a quick source of glucose, such as sweets or fruit juice, accessible. Alcohol consumption is discouraged while on this medication due to its potential to lower blood sugar levels further. Other possible side effects may include alterations in taste, nausea, vomiting, abdominal discomfort, headaches, swelling, blurred vision, and an increased risk of fractures. Weight gain may also occur in some patients. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic conditions. Prior history of heart disease should be disclosed to your physician, as this could influence treatment suitability. Regular blood sugar monitoring is advised, along with periodic blood tests to assess cell counts and liver health.